| |
|
|
|
Aldeyra Therapeutics Inc.  
|
|
5.11 0.01 (0%) |
08-21 16:00 |
|
Open: |
5.05 |
Pre close: |
5.1 |
Target:
|
6.45
|
|
High: |
5.22 |
Low: |
4.9949 |
Resistance:
|
5.52
6.00
|
|
Volume: |
52,246 |
Market Cap: |
141M |
Support:
|
4.75
3.95
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.99
 |
MACD |
MACD(12,26):
|
-0.20  |
|
MA(20): |
5.26 |
Signal(12,26,9): |
-0.21 |
|
MA(100): |
6.76 |
Stochastic Oscillator |
%K(14,3):
|
25.60 |
|
MA(250): |
8.28 |
%D(3): |
18.66 |
|
Average Volume(K) |
3-Month: |
24792
|
52-Week |
High:
|
16.70 |
|
10-Days: |
12388 |
Low: |
4.75 |
|
RSI |
RSI(14):
|
41.42 |
Change(%): |
-34.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.998 |
Return on Equity (ttm) |
-96.6 |
Shares Out. (M) |
20.11 |
|
EPS Est. Current Year |
-1.470 |
Return on Assets (ttm) |
-49.8 |
Shares Float (M) |
20.31 |
|
EPS Est. Next Year |
-1.740 |
PEG Ratio |
0.00 |
% Held by Insiders |
1.94 |
|
EPS Est. Next Quarter |
-0.370 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
73.18 |
|
Forward EPS |
-2.372 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
1290 |
|
Book Value (p.s.) |
2.490 |
EBITDA (p.s.) |
-2.316 |
P/E |
-2.56 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.05 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-41.10 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-38.65 |
P/CF |
-2.50 |
|
|
|
|
|
|
